ClinicalTrials.Veeva

Menu
A

Arizona Clinical Trials | Chandler, AZ

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

MK-1084
Docetaxel
CRB-913
MK-8527-015
Pasritamig
Vorasidenib
Maridebart Cafraglutide
MK-8527
BI 1584862

Parent organization

This site is a part of Arizona Clinical Trials

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 8 total trials

A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity (CANYON-1)

This study will assess the safety of the investigational drug CRB-913 and how it is processed in the body.The study has two parts: Part 1 will measur...

Active, not recruiting
Obese But Otherwise Healthy Participants
Drug: CRB-913
Drug: Placebo

The purpose of this study is to learn what happens to calderasib levels in a person's body over time. Researchers will measure what happens to calder...

Enrolling
Hepatic Impairment
Healthy
Drug: Calderasib

The purpose of this study is to find out whether treatment with pasritamig and docetaxel prolongs radiographic progression free survival (rPFS) (the...

Enrolling
Prostatic Neoplasms, Castration-Resistant
Drug: Docetaxel
Drug: Prednisone

The main objective of this trial will be to determine whether maridebart cafraglutide is superior to placebo on reduction in liver fat content and bo...

Enrolling
Overweight or Obesity and Elevated Liver Fat
Drug: Placebo
Drug: Maridebart cafraglutide

The objective of this study is to evaluate the pharmacokinetics, safety, and tolerability of one dose of vorasidenib in participants with severe impa...

Enrolling
Severe Hepatic Impairment
Normal Hepatic Function
Drug: Vorasidenib 20mg

This is a phase 1/2, open-label, multicenter study of intravesical Recombinant Mycobacterium Bacillus Calmette-Guérin (BCG) in participants with Non-...

Enrolling
NMIBC
Biological: Intravesical Recombinant Mycobacterium (rMBCG)

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Amgen logo
Boehringer Ingelheim logo
C
ImmunityBio logo
Janssen (J&J Innovative Medicine) logo
Servier logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems